Search results for "Therapeutics"


 
Results 11 - 20 of about 400 for "Therapeutics".
Sort by: Relevance | Newest | Oldest

April 2008

ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2008/04/

Novel metric may improve measurement of antibiotic stewardship efforts

Days of antibiotic spectrum coverage may be a more accurate metric than days of therapy for evaluating programs that promote use of narrow-spectrum antibiotic agents, a study found.
https://acphospitalist.acponline.org/weekly/archives/2021/12/22/3.htm
22 Dec 2021

May 2010

ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2010/05/

Advance care planning assessed, therapeutic heparin debated in recent COVID-19 articles

Along with an analysis of the pre-existing conditions of patients who died of COVID-19 and a point/counterpoint on use of heparin in ward patients, the latest inpatient COVID-19 research included negative trials of losartan and a potential monoclonal antibody.
https://acphospitalist.acponline.org/archives/2022/03/23/free/advance-care-planning-assessed-therapeutic-heparin-debated-in-recent-covid-19-articles.htm
23 Mar 2022

Mixed news on anticoagulation; new data on myocarditis, postexposure prophylaxis

Full-dose anticoagulation appeared to help hospitalized COVID-19 patients who weren't critically ill but not the critically ill, trials showed. Postvaccine myocarditis and pericarditis were investigated by a study, while new data and an FDA authorization supported postexposure prophylaxis for some patients.
https://acphospitalist.acponline.org/weekly/archives/2021/08/11/1.htm
11 Aug 2021

April 2009

ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2009/04/

COVID-19 research focused on anticoagulation, vaccine-induced thrombocytopenia

Two new studies support prophylactic, rather than therapeutic, anticoagulation for COVID-19 patients, and case reports provide more information about vaccine-induced immune thrombotic thrombocytopenia.
https://acphospitalist.acponline.org/weekly/archives/2021/06/16/1.htm
16 Jun 2021

October 2008

ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2008/10/

New data on tocilizumab, convalescent plasma, anticoagulation for COVID-19

Recent studies found that tocilizumab was potentially harmful for ICU patients, indicated that convalescent plasma works better with higher antibody titers delivered earlier, and offered conflicting findings on anticoagulation. Other research compared mortality from COVID-19 over time.
https://acphospitalist.acponline.org/weekly/archives/2021/01/27/1.htm
27 Jan 2021

Microbiome therapeutic reduced risk of recurrent C. difficile infection in phase 3 trial

An industry-funded trial of patients with recurrent Clostridioides difficile infection who received standard-of-care treatment with antibiotics found that those who also received the investigational drug had a 68% lower risk of recurrence than those who received placebo.
https://acphospitalist.acponline.org/archives/2022/01/26/microbiome-therapeutic-reduced-risk-of-recurrent-c-difficile.htm
26 Jan 2022

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next